SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001082554-21-000030
Filing Date
2021-11-03
Accepted
2021-11-03 06:03:50
Documents
76
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q uthr-20210930.htm   iXBRL 10-Q 2179806
2 EX-31.1 uthrex31109302021.htm EX-31.1 11816
3 EX-31.2 uthrex31209302021.htm EX-31.2 11813
4 EX-32.1 uthrex32109302021.htm EX-32.1 6638
5 EX-32.2 uthrex32209302021.htm EX-32.2 6756
  Complete submission text file 0001082554-21-000030.txt   8861419

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT uthr-20210930.xsd EX-101.SCH 53444
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT uthr-20210930_cal.xml EX-101.CAL 69403
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT uthr-20210930_def.xml EX-101.DEF 268390
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT uthr-20210930_lab.xml EX-101.LAB 686774
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT uthr-20210930_pre.xml EX-101.PRE 431978
11 EXTRACTED XBRL INSTANCE DOCUMENT uthr-20210930_htm.xml XML 1681104
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 211373575
SIC: 2834 Pharmaceutical Preparations